News in English
Enter any phrase or word you would like to search for and click .
PostNews: Interim Report
Interim Report for the third quarter
For the first time, sales during the past 12 months reached 5 MSEK. Since our previous report, much effort has gone into implementing the ambitious market expansion made possible by the capital acquisition this summer.
Learn more …
PostNews: Press Release
Leading life science tools company enters technology assessment agreement with PHI
A major publicly traded life science tools company has entered a technology assessment agreement with Phase Holographic Imaging (PHI). The purpose of the agreement is to assess PHI’s Holo¬Monitor technology for cell biology applications, primarily within immuno-oncology.
Learn more …
PostNews: Press Release
PHI and BioSpherix expand marketing partnership after scientific evaluation
In June 2018, Phase Holographic Imaging (PHI) and BioSpherix Medical entered a collaboration agreement, aiming to co-market the companies’ complementary product lines. BioSpherix develops and market advanced hermetically sealed cell incubators for the control and optimization of cell culture environments.
Learn more …
PostNews: Press Release
Cancer researchers use HoloMonitor to track skin cancer cells
Scientists at the Holographic Imaging Cytometry Center of Excellence at University of California, San Francisco, study how normal skin cells transform into aggressive skin cancer. HoloMonitor M4 plays an important role in their research.
Learn more …
PostNews: Interim Report
Interim Report for the second quarter
For the first time, sales during the past 12 months reached 5 MSEK. Since our previous report, much effort has gone into implementing the ambitious market expansion made possible by the capital acquisition this summer.
Learn more …
PostNews: Press Release
Lund University and PHI partner to develop novel 3D cell culturing methods for immunotherapy research
Based on PHI’s current HoloMonitor technology, the Department of Immunotechnology at Lund University and Phase Holographic Imaging (PHI) recently agreed to jointly develop novel 3-dimensional cell culturing methods to meet the urgent need for such methods.
Learn more …